City and university officials have announced that Orion Integrated Biosciences, Larchmont, New York, has opened a new office in Manhattan to work more closely with Kansas State University scientists and capitalize on the future opening of the National Bio and Agro-defense Facility, or NBAF.
n October 2014 the European Commission (EC) allocated €24.4 million of the European Union (EU) budget to urgently fund needs for Ebola Virus Disease (EVD) outbreak response and research. This funding has empowered the “EU research and innovation program (EURIP)”, through Horizon 2020, the necessary means to be operational in a short period of time and thus to actively participate in the response to the present EVD outbreak in West Africa. Through this initiative the EURIP has selected and rewarded five projects with scopes ranging from testing existing and novel compounds of interest for EVD treatment to large-scale clinical trials of a potential vaccine.
n October 2010 the U.S. Department of Homeland Security awarded Kansas State University Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) to use state-of-the-art infrastructure to conduct research, develop technology, and train a specialized workforce to successfully defend our nation’s agriculture economy against agro-terrorism and emerging animal pathogens.
Orion Integrated Biosciences To Present At CHI’s Targeting the Microbiome/ Discovery on Target Conference
On September 21-23 2015 Orion Integrated Biosciences will be presenting several research projects in the CHI’s conference Targeting the Microbiome. During this event Orion Integrated Biosciences will show the performance assessment of RIGEL-MTP (Molecular Taxonomic Profiling) using metegenomic samples of Ebola-infected patients and the assessment of the microbiome to determine survival to infection.
Current analysis of the #Ebola outbreak in Sierra Leon and Guinea using our motif fingerprint technology
Orion Integrated Biosciences Inc. is performing exhaustive analysis of #Ebola outbreak in W. Africa. We have identified discriminating genomic signatures and motif fingerprints for the 2014 outbreak.
Genomic Fingerprinting of the West African Outbreak In response to the global health challenges posed by the two current Ebola outbreaks, Orion Integrated Biosciences, Inc., reports a preliminary analysis of the current genomic information that could help decision-makers in the real-time deployment of available countermeasures and the risk assessment of potential vulnerabilities.